FOR IMMEDIATE RELEASE
Statement attributable to:
Beth Feldpush, DrPH
Senior Vice President of Policy and Advocacy
America’s Essential Hospitals
WASHINGTON—America’s Essential Hospitals thanks the Biden Administration for strongly supporting the 340B Drug Pricing Program in its plan to tackle high drug prices, and we urge policymakers to dismantle barriers to affordable drugs that now threaten the program.
The administration unequivocally states its support for the 340B program in its drug pricing report to the White House Competition Council. We appreciate this recognition and agree enthusiastically with it. But policies put in place before the current administration—especially deep and damaging cuts to Medicare outpatient payments to 340B hospitals—hinder the program’s ability to deliver the benefits we both agree it provides.
As policymakers consider ways to rein in runaway drug prices, we urge them to end harmful policies that undermine the 340B program and protect it from new attempts to weaken the access and equity it creates for low-income patients.
# # #
About America’s Essential Hospitals
America’s Essential Hospitals is the leading champion for hospitals and health systems dedicated to high-quality care for all, including the most vulnerable. We support our more than 300 members with advocacy, policy development, research, and education. Communities depend on essential hospitals to provide specialized, lifesaving services; train the health care workforce; advance public health and health equity; and coordinate care. Essential hospitals innovate and adapt to lead the way to more effective and efficient care. Learn more at essentialhospitals.org.